Swoop
Swoop
Patient-First Approach Propels Swoop to PM360 Elite 100 Wins
Innovation and patients are at the heart of Swoop’s mission, and that commitment has been recognized with two wins in the 2025 PM360 Elite 100 awards. Co-founder and President of MyHealthTeam and Swoop Chief Patient Officer Eric Peacock and Swoop’s marketing team led by Chief Marketing Officer Marcella Milliet Sciorra have been recognized for their […]
Conversational AI | Infographics
Swoop
Conversational AI in Pharma: Avoid the Pitfalls of Building In-House
In today’s digital world, patients and healthcare providers (HCPs) expect instant access to information. With 82% of consumers preferring conversational AI over waiting for a customer service representative, the question isn’t if pharmaceutical brands should implement a virtual agent on their website, but how.
MyHealthTeam | Patient Insights
Swoop
Understanding the Debilitating Nature of Narcolepsy in Patients’ Own Words: A Social Listening Analysis
Background Narcolepsy is a rare, chronic hypersomnolence disorder characterized by debilitating symptoms, including excessive daytime sleepiness (EDS), cataplexy, and disrupted nighttime sleep. Symptoms most typically appear during adolescence2; however, previous reports suggest that diagnosis can be complicated by lack of symptom recognition or misdiagnoses and may be delayed by >10 years. Real-world information and experiences […]
Swoop
Eric: Pioneering Patient Engagement and Education
Eric Peacock's journey from consulting and tech to healthcare all started with a book about genetics. Eric brings his empowering and transparent leadership style to Swoop.
Swoop
DSP Diagnosis: 10 Factors Pharma Marketers Should Consider
This checklist will guide you through choosing a DSP that aligns with your objectives, respects patient privacy, and leverages cutting-edge technology.
MyHealthTeam | Patient Insights
Swoop
Matching Anti-Seizure Medications’ Formulations to Patients: Why It Matters
Objective To understand the healthcare provider (HCP) and parent/caregiver dialogue regarding swallowing challenges of anti-seizure medications (ASMs) in children with epilepsy. Background Challenges swallowing oral medications among children have been shown to affect adherence to treatment. This survey is of critical importance for the practicing neurologist, as it addresses issues related to medication formulation availability […]
MyHealthTeam | Patient Insights
Swoop
Patient Reported Attitudes Towards Multiple Sclerosis Treatment
Background Obstacles exist for getting patients on disease modifying treatments (DMTs) to slow progression. Understanding patient concerns can enable neurologists to help patients overcome barriers. Objective Research was undertaken to better understand awareness, usage, and attitudes towards DMTs.
Swoop
Five fast lessons from Reuters Pharma USA 2025
Here are five quick takeaways from Reuters Pharma USA 2025
Predictive Audiences | Case Studies
Swoop
A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.